Nombre del producto |
2-[[[3 methyl-4-(2,2,2 trifluoroethoxy) 2-pyridyl]-methyl] thio]-1H-benzimidazole |
Nombre en inglés |
2-[[[3 methyl-4-(2,2,2 trifluoroethoxy) 2-pyridyl]-methyl] thio]-1H-benzimidazole; 2-[3-Methyl-4(2,2,2-trifluoroethoxy)pyrid-2yl]-Methylthio]benzimidazole; LANSOPRAZOLE SULFIDE; 2-[3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL]METHYL THIO-1H-BENZIMIDAZOLE; 2-[[3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRID-2YL]METHYLTHIO]BENZIMIDAZOLE; 2-((METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDINYL)THIO)-1H-BINZIMIDAZOLE; 2-[[(3-Methyl-4-(2,2,2-Trifluoroethoxy) Pyridinyl) Methyl] Thio]-1H-Benzimidazole; 2-[[[3-Methyl-4-(2,2,2-Trifluoroethyoxy)-2-Pyridyl]-Methyl]Thio]-1H-Benzimidazole; 2-[3-Methyl-4-(2,2,2-Trifluoroethoxy)Methylthio-1H-Benzimidazole; 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridinyl)thio)-(1H)-binzimidazole; Lansoprazole sulphide compound; 3-Methyl-4-[((2,2,2-trifluroethoxy-2-pyridinyl)methyl)thio]-1H-benzimidazole; 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfanyl)-1H-benzimidazole; 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylthio-1H-benzimidazole; 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphanyl]-1H-benzimidazole; 2-(3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methylthio-1h-benzimidazole; 3-Methyl-4-[((2,2,2-trifluoro ethoxy-2-pyridinyl)methyl)thio]-1H-Benzimidazole |
Fórmula molecular |
C16H14F3N3OS |
Peso Molecular |
353.3621 |
InChI |
InChI=1/C16H14F3N3OS/c1-10-13(20-7-6-14(10)23-9-16(17,18)19)8-24-15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22) |
Número de registro CAS |
103577-40-8 |
Estructura Molecular |
|
Densidad |
1.41g/cm3 |
Punto de fusión |
149-150℃ |
Punto de ebullición |
494.9°C at 760 mmHg |
Índice de refracción |
1.615 |
Punto de inflamación |
253.1°C |
Presión de vapor |
6.2E-10mmHg at 25°C |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|